Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2003
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003WO2001092542A3 Integrin-targeting vectors having enhanced transfection activity
05/30/2003CA2468088A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
05/30/2003CA2467958A1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna
05/30/2003CA2467930A1 Treatment of pml targeting jc virus agno
05/30/2003CA2467927A1 Antimicrobial polypeptides from pseudoplectania nigrella
05/30/2003CA2467459A1 Hip1 cancer markers
05/30/2003CA2467048A1 Method of protein purification
05/30/2003CA2466937A1 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
05/30/2003CA2464957A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003CA2364043A1 Methylotrophic bacterium for the production of recombinant proteins and other products
05/29/2003US20030101482 Compositions encoding lepidopteran-toxic polypeptides and methods of use
05/29/2003US20030100743 Nucleic acids and proteins with thioredoxin reductase activity
05/29/2003US20030100726 Secreted transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100723 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100720 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/29/2003US20030100715 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/29/2003US20030100713 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100711 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100710 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/29/2003US20030100709 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/29/2003US20030100708 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100525 Amino acid sequences; anticaner agents, monitoring, diagnosis
05/29/2003US20030100504 Treatment and diagnosis of insulin-resistant states
05/29/2003US20030100497 For stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals
05/29/2003US20030100488 Osteoprotegerin binding proteins
05/29/2003US20030100483 As preservatives; in prophylaxis and therapy of viral or microbial infection in animals and plants, and in inactivating endotoxin
05/29/2003US20030100094 Method for engineering strand-specific, sequence-specific, DNA-nicking enzymes
05/29/2003US20030100088 Protease inhibitor conjugates and antibodies useful in immunoassay
05/29/2003US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders
05/29/2003US20030100083 Preparation of pseudomonic acid A; obtain bacteria capable of producing pseudomonic acid A, culture, ferment and isolate pseudomonic acid A from culture
05/29/2003US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis
05/29/2003US20030100063 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030100061 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100053 Nucleotide sequences coding polypeptide for use in the treatment of tumor disorders
05/29/2003US20030100039 Novel human phospholipase c delta 5
05/29/2003US20030100033 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer in mammals
05/29/2003US20030100026 Stimulus-inducible protein kinase complex and methods of use therefor
05/29/2003US20030100016 Complement C3 precursor biopolymer markers predictive of Alzheimers disease
05/29/2003US20030100015 Protein biopolymer markers indicative of age matched control
05/29/2003US20030100014 Apolipoprotein biopolymer markers predictive of type II diabetes
05/29/2003US20030100013 HP biopolymer markers predictive of insulin resistance
05/29/2003US20030100012 Plasma protease C1 biopolymer markers predictive of alzheimers disease
05/29/2003US20030100011 IG lambda biopolymer markers predictive of alzheimers disease
05/29/2003US20030100010 Fibrinogen biopolymer Marker predictive of type II diabetes
05/29/2003US20030100009 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
05/29/2003US20030100007 Detection of preferential binding agents; form peptide library, incubate target, recover peptide which bind to target, expose target to non-peptide binding agent, recover bound target, determine structure of nonpeptide binding agent
05/29/2003US20030099992 Genes associated with mast cell activation
05/29/2003US20030099991 Detection of nucleotide sequences associated pain and nervous system disorders; obtain sample, incubate with probe, detect signal, recover nucleic acid, incubate with primer, amplify, evaluate for disorder
05/29/2003US20030099971 Epidermal differentiation factor
05/29/2003US20030099970 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
05/29/2003US20030099954 Adjusting preferential biopolymers; obtain biopolymer sample, insert into analytical apparatus, heat and adjust biopolymer
05/29/2003US20030099926 Response element compositions and assays employing same
05/29/2003US20030099673 Use of such polypeptides and nucleic acids encoding them as vaccines and diagnostic reagents
05/29/2003US20030099669 Method of protein production using mitochondrial translation system
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099656 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
05/29/2003US20030099652 Novel human protein tyrosine kinase
05/29/2003US20030099635 Use of oral gammaglobulin for the treatment of immune-mediated diseases
05/29/2003US20030099631 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits
05/29/2003US20030099627 Method for determining modulation of p110delta activity
05/29/2003US20030099625 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030099608 Human cytokine receptor
05/28/2003EP1314781A1 Design and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein by using the same
05/28/2003EP1314741A1 Bispecific anti-CD19 x anti-CD16 antibodies and uses thereof
05/28/2003EP1314739A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines
05/28/2003EP1313872A1 A method of producing fr901228
05/28/2003EP1313863A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313855A2 Truncated bard1 protein, and its diagnostic and therapeutic uses
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313848A1 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone
05/28/2003EP1313843A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313771A2 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
05/28/2003EP1313769A2 Antibodies to human il-1 beta
05/28/2003EP1313756A1 Antibodies specific for methylated lysines in histones
05/28/2003EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis
05/28/2003EP1313506A1 Immunologic method for the prevention of dental caries
05/28/2003EP0889949B1 Fermentation control
05/28/2003EP0686162B1 Improved method for the refolding of proteins
05/28/2003EP0449958B9 Meningococcal class 1 outer-membrane protein vaccine
05/28/2003CN1420893A Method and compositions for generating human monoclonal antibodies
05/28/2003CN1420789A Compound for targeting
05/28/2003CN1420126A Method for preparing recombinant human plasminogen kringle 5 mutant protein rhpk-5
05/27/2003US6570061 Generating transgenic animal; obtain animal blastocyst, transform with expression vector coding immunoglobulin, propagate blastocyst and recover trangenic animal
05/27/2003US6570001 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
05/27/2003US6570000 Nucleotide sequence coding monoclonal antibody for use in the treatment of viral diseases
05/27/2003US6569997 Antibody specific for H4-1BB
05/27/2003US6569995 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
05/27/2003US6569994 Human blue-light photoreceptor hCRY2
05/27/2003US6569992 Protein for use in the treatment of immunological, liver, reproductive and infectious disorders
05/27/2003US6569658 Proteins and nucleic acids which have an effect on or are related to cell cycle regulation; use in assays screening for cell cycle modulators and as therapeutics
05/27/2003US6569655 For use in therapeutics, diagnostics, and as research tools
05/27/2003US6569646 Process for the production of an enzyme preparation containing xylanase and carboxymethyl cellulase from termitomyces clypeatus having accession no 11CB-411
05/27/2003US6569645 IL-17 homologous polypeptides and therapeutic uses thereof
05/27/2003US6569643 Expression vector for use as tool in genetic engineering
05/27/2003US6569642 TNF-Related Apoptosis-Inducing Ligand (TRAIL); isolated DNA probe which hybridizes to nucleic acid of given sequence; use in purifying cells, inhibiting biological activities or as immunogens to produce antibodies
05/27/2003US6569641 Which can modify transcription, replication or stability of a DNA sequence; producing stochastically generated polynucleotide sequences; expression vectors
1 ... 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 ... 1125